Sort
59,101 grants matching “hypertension”
Actions to Decrease Disparities in Risk and Engage in Shared Support for Blood Pressure Control (ADDRESS-BP) in Blacks
$1,311,696Gbenga Godwin Ogedegbe · New York University School Of Medicine · UG3 · FY2021 · HL
Development of an Innovative Vervet (Chlorocebus aethiops sabaeus) Model of Early Alzheimer's-like Neuropathology and Symptomatology
$1,311,510Carol A. Shively · Wake Forest University Health Sciences · R24 · FY2021 · AG
COMPREHENSIVE SICKLE CELL CENTER
$1,311,435Cage S Johnson · University Of Southern California · U54 · FY2007 · HL
(INTRODUCTION) MECHANISMS OF ACCLIMATIZATION: FETUS AND ADULT
$1,311,239Lawrence D Longo · Loma Linda University · P01 · FY2012 · HD
Translational studies for identifying and targeting novel pathways in systemic sclerosis pathogenesis
$1,310,592Robert A Lafyatis · University Of Pittsburgh At Pittsburgh · P50 · FY2018 · AR
METABOLIC DETERMINANTS OF HYPERTENSION
$1,310,568University Of Michigan At Ann Arbor · P01 · FY2000 · HL
Effectiveness of Implementing an Intensive Blood Pressure Reduction Intervention on Cognitive Decline in Low-income and Minority Hypertensive Patients
$1,310,292Katherine Teresa Mills · Tulane University Of Louisiana · R33 · FY2021 · AG
Validation of small vessel vascular contributions to cognitive impairment and dementia (VCID) biomarkers
$1,309,997Hanzhang Lu · Johns Hopkins University · U01 · FY2024 · NS
Validation of small vessel vascular contributions to cognitive impairment and dementia (VCID) biomarkers
$1,309,997Hanzhang Lu · Johns Hopkins University · U01 · FY2023 · NS
Validation of small vessel vascular contributions to cognitive impairment and dementia (VCID) biomarkers
$1,309,997Hanzhang Lu · Johns Hopkins University · U01 · FY2025 · NS
The VETSA longitudinal twin study of cognition and aging
$1,309,853William S Kremen · University Of California, San Diego · R01 · FY2011 · AG
MOLECULAR EPIDEMIOLOGY OF ESSENTIAL HYPERTENSION
$1,309,398Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston · R37 · FY2007 · HL
Translational studies for identifying and targeting novel pathways in systemic sclerosis pathogenesis
$1,309,324Robert A Lafyatis · University Of Pittsburgh At Pittsburgh · P50 · FY2017 · AR
Maternofetal Signaling and Lifelong Consequences\Overall
$1,308,996Kent L.r. Thornburg · Oregon Health & Science University · P01 · FY2011 · HD
Micronutrients, stroke and cognition in aging
$1,308,683Tufts University Boston · R01 · FY2003 · AG
Involving Communities in Delivering and Disseminating Health Disparity Interventions
$1,308,559Ashwini Sehgal · Case Western Reserve University · U54 · FY2019 · MD
Genetic Analysis of Complex Inflammatory Disorders
$1,308,268Daniel Kastner · National Human Genome Research Institute · ZIA · FY2016 · HG
American Indian and Alaska Native Health Disparities
$1,308,192Spero M Manson · University Of Colorado Denver · U54 · FY2018 · MD
HMO Research Network Cardiovascular Research Network
$1,307,805Alan S Go · Kaiser Foundation Research Institute · U19 · FY2009 · HL
MOLECULAR EPIDEMIOLOGY OF ESSENTIAL HYPERTENSION
$1,306,995Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston · R37 · FY2006 · HL
Development of an Innovative Vervet (Chlorocebus aethiops sabaeus) Model of Early Alzheimer's-like Neuropathology and Symptomatology
$1,305,223Carol A. Shively · Wake Forest University Health Sciences · R24 · FY2022 · AG
Chronic Kidney Disease in Children (CKiD)
$1,304,705Susan L Furth · Children'S Hosp Of Philadelphia · U01 · FY2024 · DK
Actions to Decrease Disparities in Risk and Engage in Shared Support for Blood Pressure Control (ADDRESS-BP) in Blacks
$1,304,038Gbenga Godwin Ogedegbe · New York University School Of Medicine · UH3 · FY2025 · HL
Neurochemical Actions of Psychotropic Drugs
$1,303,838Solomon H Snyder · Johns Hopkins University · R01 · FY2011 · MH
Neurochemical Actions of Psychotropic Drugs
$1,303,834Solomon H Snyder · Johns Hopkins University · R01 · FY2012 · MH